Reviva Pharmaceuticals (RVPH) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Reviva Pharmaceuticals
Is Reviva Pharmaceuticals a buy right now? The alternative data says hold. This RVPH stock analysis is built on the 25+ alternative data signals AltIndex tracks on Reviva Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 46/100: a Hold. The stock trades at $0.53 with a $7M market cap.
The soft spots over the past 90 days: web traffic down 27.9% to 16K monthly visits, and headcount (according to LinkedIn) down 14.3% to 18 employees. The rest of the signal set is holding steady, which keeps RVPH at a hold rather than a sell.
RVPH’s broader alt-data profile also covers X followers (497), and sentiment (50/100). Every signal links to its own page with full history, the RVPH technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on RVPH is just below.
Reviva Pharmaceuticals AI Stock Analysis
Reviva Pharmaceuticals is a pharmaceutical company focused on discovering and developing novel therapies for the treatment of diseases affecting the central nervous system. The company aims to improve patient outcomes through innovative therapeutic solutions, addressing significant unmet medical needs and leveraging its proprietary technology platform.
Analysis generated September 3, 2026.
Recent Reviva Pharmaceuticals Stock Alerts
|
Reviva Pharmaceuticals | September 3 Price is down by -8.4% in the last 24h. |
|
Reviva Pharmaceuticals | September 1 Price is up by 6.3% in the last 24h. |
|
Reviva Pharmaceuticals | August 31 Price is down by -9.4% in the last 24h. |
|
Reviva Pharmaceuticals | August 27 Price is down by -6.8% in the last 24h. |
Reviva Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 16K | 27.9% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 18 | 14.3% | |
| Sentiment | 50 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 2 | 92.0% | |
| Stocktwits Mentions | 3 | 78.6% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 5K | 3.2% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 497 | 1.4% |
About Reviva Pharmaceuticals (RVPH)
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
| Price | $0.53 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $7M |
| Year Range | $0 – $17 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Reviva Pharmaceuticals News
View more →
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public OfferingMarch 18 - GlobeNewswire |
|
 |
Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026January 11 - Yahoo Entertainment |
Delisting of Securities from The Nasdaq Stock MarketJuly 10 - GlobeNewswire |
|
Reviva Reports First Quarter 2026 Financial Results and Recent Business HighlightsMay 13 - GlobeNewswire |
|
Reviva Reports Full Year 2025 Financial Results and Recent Business HighlightsMarch 30 - GlobeNewswire |
See Reviva Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for RVPH, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEReviva Pharmaceuticals Earnings & Financial Performance
View all earnings →Reviva Pharmaceuticals Insider Trading Activity
View all →| No recent insider transactions on file. |
Reviva Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Reviva Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
AIM ImmunoTechAIM |
$0.23 2.6% | $7M | 59 |
 |
Creative Medical TechCELZ |
$1.11 4.7% | $7M | 42 |
 |
Bolt BiotherapeuticsBOLT |
$3.90 0.1% | $8M | 50 |
 |
Brainstorm CellBCLI |
$1.05 1.9% | $8M | 46 |
 |
XTL BiopharmaceuticalsXTLB |
$2.53 1.2% | $7M | 50 |
Explore Reviva Pharmaceuticals Data
Frequently Asked Questions: Reviva Pharmaceuticals (RVPH)
Reviva Pharmaceuticals has an AltIndex AI Score of 46/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
46/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Reviva Pharmaceuticals (RVPH) stock is $0.53 with a market cap of $7M.
As of today, Reviva Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Reviva Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Reviva Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The RVPH stock price chart above shows Reviva Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Reviva Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Reviva Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
